Home | Legal - Law | Medical Malpractice
Biotechnology company Amgen in a Securities and Exchange Commission filing on Tuesday said that it has received a subpoena from the New York state attorney general, who has requested documents related to its sales and marketing practices, Bloomberg/Los Angeles Times reports. Amgen said it received the subpoena on May 10 and plans to fully cooperate with the attorney general. The subpoena was received on the same day an FDA advisory panel recommended that new restrictions be placed on prescribing Amgen's anemia drugs, Aranesp and Epogen, after studies found that high doses of the drugs can lead to increased risk of heart attack, stroke and death. One week later, CMS announced that it would stop Medicare payments for several unapproved uses of the anemia drugs (Bloomberg/Los Angeles Times, 5/23). "Reprinted with permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Article Source: http://www.share.onlypunjab.com
To learn more information, please visit at www.kaisernetwork.org
Please Rate this Article
5 out of 54 out of 53 out of 52 out of 51 out of 5
Not yet Rated
